Treatment Action Group

Crisis of confidence in the WHO's ability to produce normative guidance for the treatment of RR-/MDR-TB

Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.

Read More →

TAG is hiring: TB Project Officer

Treatment Action Group (TAG) is seeking a highly motivated and organized TB Project Officer to support TAG’s advocacy portfolio on TB. The deadline for applications is 19 June 2019.

Read More →

Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB

Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.

Read More →

An Activist’s Guide to Rifapentine

The guide details important efficacy, safety, and access information on rifapentine, a game-changing drug for treating TB infection in order to prevent active TB disease.

Read More →

TAGline May 2019: Nothing About Us Without Us

This TAGline is all about the importance of community engagement in research to end the epidemics of HIV, HCV, and TB. As this edition’s cover shows, protestors at the “Storm the NIH” demonstration and die-in in May 1990 demanded political will and funding for research, and equitable access to treatment for HIV. This bold and knowledgeable action brought about a massive increase to investment in HIV research, and extensive changes to how AIDS clinical trials were conducted.

Read More →

TB LAM testing briefs

Two important tools for activists to use with donors and national TB programs in advocating for increased scale-up of the inexpensive, urine TB LAM test - an essential diagnostic test for TB in people living with HIV.

Read More →

TB CAB statement on M72/AS01E TB vaccine candidate development

Statement by the Global TB Community Advisory Board to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate

Read More →

TAG statement on FDA priority review of pretomanid

Statement from Treatment Action Group on FDA priority peview of TB Alliance’s new anti-TB drug pretomanid.

Read More →

Advocacy webinar to prioritize TB in 2019 PEPFAR COPs - materials now available online

Treatment Action Group (TAG), AVAC, the Elizabeth Glaser Pediatric AIDS Foundation, Health GAP, IMPAACT4TB, and RESULTS hosted a webinar on 23 January 2019 on how to strategize and engage in PEPFAR Country Operational Plans (COPs) planning to address and strengthen the global response to TB through PEPFAR, and introduced tools to galvanize advocacy efforts.

Read More →

Advocacy webinar to prioritize TB in 2019 PEPFAR COPs

Back by popular demand! As tuberculosis (TB) is the leading global killer of people living with HIV, TB programming must be prioritized and integrated within life-saving bilateral efforts such as PEPFAR. The expected release of the PEPFAR Country Operational Plans (COPs) provides a critical opportunity for advocates to ensure that the latest developments in TB treatment, prevention and diagnostics are implemented within PEPFAR countries.

Read More →

Page 1 of 14 · Total posts: 10

1 2 Last→